Additionally, SVIP undergoes DNA hypermethylation also in esophageal (8 of 35; 23%) and cervical (3 of 14; 21%) cancers and hematological malignancies (22 of 154; 14%), particularly B cell lymphoma (15 of 45; 33%). This evidence concerns the gene SVIP and hematologic disorder.